Journal of Diabetes and Obesity
Efficacy of laparoscopic sleeve gastrectomy on type 2 diabetes with BMI less than 35: a retrospective study
- 1Department of Laparoscopic and Metabolic Surgery, Sunrise Hospital, Kakkanad, Kochi 682030, India
- 2Department of Gastroenterology, Sunrise Hospital, Kakkanad, Kochi 682030, India
- 3Department of Diabetology, Sunrise Hospital, Kakkanad, Kochi 682030, India
- 4Department of Anesthesiology, Sunrise Hospital, Kakkanad, Kochi 682030, India
- 5Department of Bio-statistics, Sunrise Hospital, Kakkanad, Kochi 682030, India
- 6Department of Dietetics, Sunrise Hospital, Kakkanad, Kochi 682030, India, Data collection and compilation
Ramakrishnapillai Padmakumar, Consultant Surgeon, Department of Laparoscopic and Metabolic Surgery, Sunrise Hospital, Seaport-Airport Road, Kakkanad, Kochi 682030, India, Tel: 91-944-7230370; Fax: 91-484-2428917; E-mail: email@example.com
Padmakumar R., et al. Efficacy of Laparoscopic Sleeve Gastrectomy in Type 2 Diabetes Even With BMI Less than 35: A Retrospective Study. (2015) J Diabetes Obes 2(1): 38- 42.
© 2015 Padmakumar R.P. This is an Open access article distributed under the terms of Creative Commons Attribution 4.0 International License.
Objective: To evaluate the effectiveness of Laparoscopic Sleeve Gastrectomy (LSG) for resolving type 2 diabetes in patients with BMI >30 kg/m2. Methods: A retrospective study was conducted on 90 type 2 diabetic patients with BMI>30 kg/m2 who underwent LSG at Sunrise Hospital, Kochi, India, from September 2009 to February 2014. In this study, we compared preoperative parameters such as BMI, HbA1c and diabetic medications with postoperative parameters during periodic reviews. Results: Complete resolution of type 2 diabetes found in 86.6%, 91.1%, and 88.4% in patients with obese class I, II & III respectively. The complete resolution of diabetes (F=0.421, P=0.658) and drop in HbA1c (F=0.172, P=0.842) among the BMI groups were statistically not significant, i.e. class I obese patients were equally benefited compared to class II and class III obese patients. Co-morbidities also resolved to a good extent; sleep apnea 100%, fatty liver 89.47%, dyslipidemia 88.57%, polycystic ovarian disease 83.33% and hypertension 82.22%. Minor complications were reported in 3.84%, whereas no complications in 96.16% of the patients. Conclusion: Laparoscopic sleeve gastrectomy was found to be an effective intervention for obese type 2 diabetic patients, even when BMI is 30-34.9 kg/m2.